Bank of New York Mellon »

Biosante Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.0M 126k 55.14
2023-09-30 $7.2M 124k 58.06
2023-06-30 $6.1M 114k 53.83
2023-03-31 $4.3M 110k 39.72
2022-12-31 $4.6M 114k 40.23
2022-09-30 $3.9M 121k 32.03
2022-06-30 $3.6M 121k 29.67
2022-03-31 $3.5M 123k 28.11
2021-12-31 $6.5M 141k 46.18
2021-09-30 $3.1M 96k 32.81
2021-06-30 $3.3M 94k 35.04
2021-03-31 $3.6M 101k 36.15
2020-12-31 $3.0M 104k 29.04
2020-09-30 $3.1M 109k 28.20
2020-06-30 $3.4M 106k 32.54
2020-03-31 $4.3M 105k 40.74
2019-12-31 $6.7M 109k 61.68
2019-09-30 $7.9M 109k 72.89
2019-06-30 $9.0M 109k 82.21
2019-03-31 $7.4M 105k 70.53
2018-12-31 $6.1M 135k 45.02
2018-09-30 $7.6M 134k 56.55
2018-06-30 $9.1M 136k 66.80
2018-03-31 $7.5M 129k 58.23
2017-12-31 $13M 196k 64.40
2017-06-30 $5.9M 126k 46.80
2017-03-31 $7.1M 143k 49.51
2016-12-31 $9.9M 163k 60.63
2016-09-30 $13M 194k 66.36
2016-06-30 $6.7M 120k 55.81